Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients
Identifieur interne : 005E64 ( Main/Curation ); précédent : 005E63; suivant : 005E65Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients
Auteurs : Mostafa A. Elgohary [Égypte] ; Jonathan G. DowlerSource :
- Clinical & Experimental Ophthalmology [ 1442-6404 ] ; 2006-08.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Cataract (epidemiology), Cataract (etiology), Diabetes Complications, Female, Humans, Incidence, Laser Therapy (statistics & numerical data), Lens Capsule, Crystalline (pathology), Lens Capsule, Crystalline (surgery), Lens Implantation, Intraocular, Male, Middle Aged, Nd:YAG, Phacoemulsification, Postoperative Complications (epidemiology), Postoperative Complications (etiology), Proportional Hazards Models, Retrospective Studies, Risk Factors, capsulotomy, cataract, diabetes mellitus, incidence, intraocular, lens, phacoemulsification.
- MESH :
- epidemiology : Cataract, Postoperative Complications.
- etiology : Cataract, Postoperative Complications.
- pathology : Lens Capsule, Crystalline.
- statistics & numerical data : Laser Therapy.
- surgery : Lens Capsule, Crystalline.
- Adult, Aged, Aged, 80 and over, Diabetes Complications, Female, Humans, Incidence, Lens Implantation, Intraocular, Male, Middle Aged, Phacoemulsification, Proportional Hazards Models, Retrospective Studies, Risk Factors.
Abstract
Purpose: To estimate the cumulative incidence and identify the risk factors of posterior capsule opacification (PCO) that required Nd:YAG capsulotomy in non‐diabetic and diabetic patients. Methods: Retrospective case‐note review of 806 consecutive patients that underwent phacoemulsification and intraocular lens (IOL) implantation, 327 (40.6%) of whom were diabetic. Results: The cumulative incidence of Nd:YAG capsulotomy were 10.6%, 14.8%, 21.2% and 28.6% in non‐diabetic patients; and 9%, 9.4%, 15.3% and 5.3% in diabetic patients after 1, 2, 3 and 4 years, respectively. A multivariate Cox regression analysis showed that, over the follow‐up period, diabetes mellitus was associated with a decreased risk of Nd:YAG capsulotomy (hazard ratio [HR] = 0.69; 95% confidence interval [CI] 0.47–0.99; P = 0.047), whereas age of 65 years or younger (HR = 1.58; 95% CI 1.09–2.27; P = 0.02), polymethylmethacrylate (PMMA) (HR = 3.98; 95% CI 1.60–9.95; P = 0.003) or plate‐haptic silicone IOLs (HR = 3.75; 95% CI 1.60–8.80; P = 0.002) in comparison with three‐piece silicone IOLs, postoperative inflammation (HR = 2.62; 95% CI 1.56–4.42; P < 0.001) and pars plana vitrectomy (HR = 1.85; 95% CI 1.20–2.83; P = 0.005) were associated with an increased risk. Subgroup analysis showed that in non‐diabetic patients, male gender (HR = 1.63; 95% CI 1.04–2.57; P = 0.03) was an additional risk factor and in diabetic patients there was no significant association between diabetes type, duration or retinopathy grade and the risk of Nd:YAG capsulotomy. Conclusion: Although diabetes mellitus appears to be associated with a lower long‐term incidence and a decreased risk of Nd:YAG capsulotomy, younger age, pars plana vitrectomy, postoperative inflammation, plate‐haptic silicone and PMMA IOLs in addition to male gender in non‐diabetic patients appear to be associated with a greater risk. Estimation of the incidence and risk factors of PCO should help in patient counselling and to design methods to reduce or prevent its development.
Url:
DOI: 10.1111/j.1442-9071.2006.01263.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C40
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :000C40
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001D57
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001769
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001769
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001584
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000972
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000972
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000972
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006105
Links to Exploration step
ISTEX:F6C4228C5A4E572E0AB6ECF415384BFDFE4473FECuration
No country items
Mostafa A. Elgohary<affiliation><wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Égypte</country>
<wicri:regionArea>Tanta Ophthalmology University Hospital, Tanta</wicri:regionArea>
<wicri:noRegion>Tanta</wicri:noRegion>
</affiliation>
<affiliation><wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients</title>
<author><name sortKey="Elgohary, Mostafa A" sort="Elgohary, Mostafa A" uniqKey="Elgohary M" first="Mostafa A" last="Elgohary">Mostafa A. Elgohary</name>
</author>
<author><name sortKey="Dowler, Jonathan G" sort="Dowler, Jonathan G" uniqKey="Dowler J" first="Jonathan G" last="Dowler">Jonathan G. Dowler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1111/j.1442-9071.2006.01263.x</idno>
<idno type="url">https://api.istex.fr/document/F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C40</idno>
<idno type="wicri:Area/Istex/Curation">000C40</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D57</idno>
<idno type="wicri:doubleKey">1442-6404:2006:Elgohary M:incidence:and:risk</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16925699</idno>
<idno type="wicri:Area/PubMed/Corpus">001769</idno>
<idno type="wicri:Area/PubMed/Curation">001769</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001584</idno>
<idno type="wicri:Area/Ncbi/Merge">000972</idno>
<idno type="wicri:Area/Ncbi/Curation">000972</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000972</idno>
<idno type="wicri:doubleKey">1442-6404:2006:Elgohary M:incidence:and:risk</idno>
<idno type="wicri:Area/Main/Merge">006105</idno>
<idno type="wicri:Area/Main/Curation">005E64</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients</title>
<author><name sortKey="Elgohary, Mostafa A" sort="Elgohary, Mostafa A" uniqKey="Elgohary M" first="Mostafa A" last="Elgohary">Mostafa A. Elgohary</name>
<affiliation><wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Égypte</country>
<wicri:regionArea>Tanta Ophthalmology University Hospital, Tanta</wicri:regionArea>
<wicri:noRegion>Tanta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dowler, Jonathan G" sort="Dowler, Jonathan G" uniqKey="Dowler J" first="Jonathan G" last="Dowler">Jonathan G. Dowler</name>
<affiliation><wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinical & Experimental Ophthalmology</title>
<idno type="ISSN">1442-6404</idno>
<idno type="eISSN">1442-9071</idno>
<imprint><publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2006-08">2006-08</date>
<biblScope unit="volume">34</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="526">526</biblScope>
<biblScope unit="page" to="534">534</biblScope>
</imprint>
<idno type="ISSN">1442-6404</idno>
</series>
<idno type="istex">F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE</idno>
<idno type="DOI">10.1111/j.1442-9071.2006.01263.x</idno>
<idno type="ArticleID">CEO1263</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1442-6404</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cataract (epidemiology)</term>
<term>Cataract (etiology)</term>
<term>Diabetes Complications</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Laser Therapy (statistics & numerical data)</term>
<term>Lens Capsule, Crystalline (pathology)</term>
<term>Lens Capsule, Crystalline (surgery)</term>
<term>Lens Implantation, Intraocular</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nd:YAG</term>
<term>Phacoemulsification</term>
<term>Postoperative Complications (epidemiology)</term>
<term>Postoperative Complications (etiology)</term>
<term>Proportional Hazards Models</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>capsulotomy</term>
<term>cataract</term>
<term>diabetes mellitus</term>
<term>incidence</term>
<term>intraocular</term>
<term>lens</term>
<term>phacoemulsification</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Cataract</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cataract</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lens Capsule, Crystalline</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Laser Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Lens Capsule, Crystalline</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Diabetes Complications</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Lens Implantation, Intraocular</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Phacoemulsification</term>
<term>Proportional Hazards Models</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose: To estimate the cumulative incidence and identify the risk factors of posterior capsule opacification (PCO) that required Nd:YAG capsulotomy in non‐diabetic and diabetic patients. Methods: Retrospective case‐note review of 806 consecutive patients that underwent phacoemulsification and intraocular lens (IOL) implantation, 327 (40.6%) of whom were diabetic. Results: The cumulative incidence of Nd:YAG capsulotomy were 10.6%, 14.8%, 21.2% and 28.6% in non‐diabetic patients; and 9%, 9.4%, 15.3% and 5.3% in diabetic patients after 1, 2, 3 and 4 years, respectively. A multivariate Cox regression analysis showed that, over the follow‐up period, diabetes mellitus was associated with a decreased risk of Nd:YAG capsulotomy (hazard ratio [HR] = 0.69; 95% confidence interval [CI] 0.47–0.99; P = 0.047), whereas age of 65 years or younger (HR = 1.58; 95% CI 1.09–2.27; P = 0.02), polymethylmethacrylate (PMMA) (HR = 3.98; 95% CI 1.60–9.95; P = 0.003) or plate‐haptic silicone IOLs (HR = 3.75; 95% CI 1.60–8.80; P = 0.002) in comparison with three‐piece silicone IOLs, postoperative inflammation (HR = 2.62; 95% CI 1.56–4.42; P < 0.001) and pars plana vitrectomy (HR = 1.85; 95% CI 1.20–2.83; P = 0.005) were associated with an increased risk. Subgroup analysis showed that in non‐diabetic patients, male gender (HR = 1.63; 95% CI 1.04–2.57; P = 0.03) was an additional risk factor and in diabetic patients there was no significant association between diabetes type, duration or retinopathy grade and the risk of Nd:YAG capsulotomy. Conclusion: Although diabetes mellitus appears to be associated with a lower long‐term incidence and a decreased risk of Nd:YAG capsulotomy, younger age, pars plana vitrectomy, postoperative inflammation, plate‐haptic silicone and PMMA IOLs in addition to male gender in non‐diabetic patients appear to be associated with a greater risk. Estimation of the incidence and risk factors of PCO should help in patient counselling and to design methods to reduce or prevent its development.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005E64 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 005E64 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= HapticV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE |texte= Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |